Ascendis Pharma A (ASND) Interest & Investment Income (2016 - 2025)
Historic Interest & Investment Income for Ascendis Pharma A (ASND) over the last 12 years, with Q3 2025 value amounting to $7.1 million.
- Ascendis Pharma A's Interest & Investment Income fell 7727.88% to $7.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $187.7 million, marking a year-over-year increase of 4677.68%. This contributed to the annual value of $101.9 million for FY2024, which is 2204.09% up from last year.
- Per Ascendis Pharma A's latest filing, its Interest & Investment Income stood at $7.1 million for Q3 2025, which was down 7727.88% from $62.3 million recorded in Q2 2025.
- Over the past 5 years, Ascendis Pharma A's Interest & Investment Income peaked at $88.0 million during Q4 2024, and registered a low of $174619.4 during Q2 2021.
- In the last 5 years, Ascendis Pharma A's Interest & Investment Income had a median value of $30.4 million in 2025 and averaged $32.3 million.
- Its Interest & Investment Income has fluctuated over the past 5 years, first skyrocketed by 4336398.48% in 2022, then crashed by 9198.32% in 2024.
- Quarter analysis of 5 years shows Ascendis Pharma A's Interest & Investment Income stood at $24.9 million in 2021, then plummeted by 86.48% to $3.4 million in 2022, then soared by 1090.61% to $40.1 million in 2023, then surged by 119.22% to $88.0 million in 2024, then crashed by 91.98% to $7.1 million in 2025.
- Its Interest & Investment Income stands at $7.1 million for Q3 2025, versus $62.3 million for Q2 2025 and $30.4 million for Q1 2025.